Cargando…
Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families
Biotinidase deficiency is an autosomal recessive, multiple carboxylase deficiency usually associated with seizures, eczema, hypotonia, visual disturbances, hearing loss, and developmental delays. Only a handful of cases of biotinidase deficiency that had clinical features of neuromyelitis optica spe...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900663/ https://www.ncbi.nlm.nih.gov/pubmed/35265569 http://dx.doi.org/10.3389/fped.2021.829251 |
_version_ | 1784664169843261440 |
---|---|
author | Naseer, Muhammad Imran Pushparaj, Peter Natesan Abdulkareem, Angham Abdulrahman Muthaffar, Osama Y. |
author_facet | Naseer, Muhammad Imran Pushparaj, Peter Natesan Abdulkareem, Angham Abdulrahman Muthaffar, Osama Y. |
author_sort | Naseer, Muhammad Imran |
collection | PubMed |
description | Biotinidase deficiency is an autosomal recessive, multiple carboxylase deficiency usually associated with seizures, eczema, hypotonia, visual disturbances, hearing loss, and developmental delays. Only a handful of cases of biotinidase deficiency that had clinical features of neuromyelitis optica spectrum disorder have been reported in the literature. The case report study is about the clinical and genetic features of two pediatric patients from different families with biotinidase deficiency whose brain and spine MRI scans were suggestive of neuromyelitis optica. Neither child improved with immunotherapy. They come from a first-degree blood-related family. In both cases, a deficiency of the enzyme biotinidase was detected. The missense variant NM_001370658.1 (BTD):c.1612C>T (p.Arg538Cys) NM_000060.4 in exon 4 was identified by whole-exome sequencing. The identified sequence variation was validated using Sanger sequencing analysis. The intake of biotin resulted in clinical improvement. After a follow-up period of 12 months, the patient was gradually weaned from tracheostomy. His vision had improved significantly. He was able to walk and run independently. In conclusion, biotinidase deficiency is a rare and treatable cause of neuromyelitis optica. Early diagnosis can prevent poor clinical outcomes. Biotinidase enzyme levels should be considered as part of the examination algorithm for neuromyelitis optica spectrum disorder. |
format | Online Article Text |
id | pubmed-8900663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89006632022-03-08 Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families Naseer, Muhammad Imran Pushparaj, Peter Natesan Abdulkareem, Angham Abdulrahman Muthaffar, Osama Y. Front Pediatr Pediatrics Biotinidase deficiency is an autosomal recessive, multiple carboxylase deficiency usually associated with seizures, eczema, hypotonia, visual disturbances, hearing loss, and developmental delays. Only a handful of cases of biotinidase deficiency that had clinical features of neuromyelitis optica spectrum disorder have been reported in the literature. The case report study is about the clinical and genetic features of two pediatric patients from different families with biotinidase deficiency whose brain and spine MRI scans were suggestive of neuromyelitis optica. Neither child improved with immunotherapy. They come from a first-degree blood-related family. In both cases, a deficiency of the enzyme biotinidase was detected. The missense variant NM_001370658.1 (BTD):c.1612C>T (p.Arg538Cys) NM_000060.4 in exon 4 was identified by whole-exome sequencing. The identified sequence variation was validated using Sanger sequencing analysis. The intake of biotin resulted in clinical improvement. After a follow-up period of 12 months, the patient was gradually weaned from tracheostomy. His vision had improved significantly. He was able to walk and run independently. In conclusion, biotinidase deficiency is a rare and treatable cause of neuromyelitis optica. Early diagnosis can prevent poor clinical outcomes. Biotinidase enzyme levels should be considered as part of the examination algorithm for neuromyelitis optica spectrum disorder. Frontiers Media S.A. 2022-02-21 /pmc/articles/PMC8900663/ /pubmed/35265569 http://dx.doi.org/10.3389/fped.2021.829251 Text en Copyright © 2022 Naseer, Pushparaj, Abdulkareem and Muthaffar. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Naseer, Muhammad Imran Pushparaj, Peter Natesan Abdulkareem, Angham Abdulrahman Muthaffar, Osama Y. Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families |
title | Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families |
title_full | Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families |
title_fullStr | Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families |
title_full_unstemmed | Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families |
title_short | Whole-Exome Sequencing Reveals a Missense Variant c.1612C>T (p.Arg538Cys) in the BTD Gene Leading to Neuromyelitis Optica Spectrum Disorder in Saudi Families |
title_sort | whole-exome sequencing reveals a missense variant c.1612c>t (p.arg538cys) in the btd gene leading to neuromyelitis optica spectrum disorder in saudi families |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900663/ https://www.ncbi.nlm.nih.gov/pubmed/35265569 http://dx.doi.org/10.3389/fped.2021.829251 |
work_keys_str_mv | AT naseermuhammadimran wholeexomesequencingrevealsamissensevariantc1612ctparg538cysinthebtdgeneleadingtoneuromyelitisopticaspectrumdisorderinsaudifamilies AT pushparajpeternatesan wholeexomesequencingrevealsamissensevariantc1612ctparg538cysinthebtdgeneleadingtoneuromyelitisopticaspectrumdisorderinsaudifamilies AT abdulkareemanghamabdulrahman wholeexomesequencingrevealsamissensevariantc1612ctparg538cysinthebtdgeneleadingtoneuromyelitisopticaspectrumdisorderinsaudifamilies AT muthaffarosamay wholeexomesequencingrevealsamissensevariantc1612ctparg538cysinthebtdgeneleadingtoneuromyelitisopticaspectrumdisorderinsaudifamilies |